Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
NCT04460560
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hepatorenal Syndrome
Interventions
DRUG:
Terlipressin
Sponsor
University of Pennsylvania